Kelonia Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 62

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7B

Kelonia General Information

Description

Developer of a genetic medicine platform designed to enable targeted delivery of therapeutic genetic material. The company's platform offers tissue-specific delivery technology, engineered viral systems, and in vivo cell therapy capabilities, enabling healthcare researchers and clinicians to develop and administer precise treatments for complex diseases.

Contact Information

Formerly Known As
Elcano Therapeutics, Viralogic Therapeutics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 34 Farnsworth Street
  • 3rd Floor
  • Boston, MA 02210
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Parent Company
Corporate Office
  • 34 Farnsworth Street
  • 3rd Floor
  • Boston, MA 02210
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kelonia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 26-Jun-2026 $7B Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 14-Apr-2022 Completed Clinical Trials - Phase 1
2. Seed Round $7.5M $7.5M Completed Clinical Trials - Phase 1
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view Kelonia’s complete valuation and funding history, request access »

Kelonia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Kelonia’s complete cap table history, request access »

Kelonia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genetic medicine platform designed to enable targeted delivery of therapeutic genetic material. The compa
Drug Discovery
Boston, MA
62 As of 2026

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kelonia Competitors (1)

One of Kelonia’s competitors is Vir Biotechnology, a Formerly VC-backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vir Biotechnology Formerly VC-backed San Francisco, CA
You’re viewing 1 of 1 competitors. Get the full list »

Kelonia Patents

Kelonia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240150788-A1 Lymphocyte targeted lentiviral vectors Active 26-Feb-2021

Kelonia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kelonia Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alta Partners Venture Capital Minority
Crown Venture Fund Venture Capital Minority
Horizons Ventures Venture Capital Minority
LabCentral Accelerator/Incubator
Venrock Venture Capital Minority
To view Kelonia’s complete investors history, request access »

Kelonia FAQs

  • When was Kelonia founded?

    Kelonia was founded in 2021.

  • Where is Kelonia headquartered?

    Kelonia is headquartered in Boston, MA.

  • What is the size of Kelonia?

    Kelonia has 62 total employees.

  • What industry is Kelonia in?

    Kelonia’s primary industry is Drug Discovery.

  • Is Kelonia a private or public company?

    Kelonia is a Private company.

  • What is the current valuation of Kelonia?

    The current valuation of Kelonia is .

  • What is Kelonia’s current revenue?

    The current revenue for Kelonia is .

  • How much funding has Kelonia raised over time?

    Kelonia has raised $57.5M.

  • Who are Kelonia’s investors?

    Alta Partners, Crown Venture Fund, Horizons Ventures, LabCentral, and Venrock have invested in Kelonia.

  • Who are Kelonia’s competitors?

    Vir Biotechnology is a competitor of Kelonia.

  • When was Kelonia acquired?

    Kelonia was acquired on 26-Jun-2026.

  • Who acquired Kelonia?

    Kelonia was acquired by Lilly USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process